Exenatide

Details

Files

Generic Name:

Exenatide

Project Status:

Complete

Therapeutic Area:

Diabetes mellitus, type 2

Manufacturer:

Eli Lilly Canada

Call for patient/clinician input open:

August 9, 2011

Brand Name:

Byetta

Project Line:

Reimbursement Review

Project Number:

SR0246-000

Call for patient/clinician input closed:

September 14, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes mellitus, Type 2

Recommendation Type:

Do not list

Final Recommendation:

July 19, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : August 23, 2011